Medentika: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Medentika
Largest movements
- Cash +€42,395
up €42,395 (+210%), from €20,220 to €62,615
mainly Net result for the year (+€75,885) and Deferred charges and accrued income (+€19,757)
- Current investments +€37,373
up €37,373 (+49.8%), from €75,000 to €112,373
- Deferred charges and accrued income -€19,757
down €19,757 (-65.9%), from €29,969 to €10,212
- Receivables within one year +€11,728
up €11,728 (+42.0%), from €27,950 to €39,677
of which Other amounts receivable: +€6,239
- Profit (loss) carried forward +€75,085
up €75,085 (+57.4%), from €130,804 to €205,889
- Tax, wage and social debts -€2,380
down €2,380 (-13.3%), from €17,951 to €15,570
of which Taxes: -€2,862
- Gross operating margin -€73,492
down €73,492 (-42.9%), from €171,249 to €97,756
- Taxes -€17,146
down €17,146 (-43.8%), from €39,125 to €21,979
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €156,728 | €227,234 | +€70,506 | +45.0% |
| Fixed assets | 21/28 | €3,589 | €2,357 | -€1,233 | -34.3% |
| Tangible fixed assets | 22/27 | €3,589 | €2,357 | -€1,233 | -34.3% |
| Plant, machinery and equipment | 23 | €3,589 | €2,357 | -€1,233 | -34.3% |
| Current assets | 29/58 | €153,139 | €224,877 | +€71,739 | +46.8% |
| Amounts receivable within one year | 40/41 | €27,950 | €39,677 | +€11,728 | +42.0% |
| Trade receivables | 40 | €1,550 | €7,038 | +€5,488 | +354% |
| Other amounts receivable | 41 | €26,400 | €32,639 | +€6,239 | +23.6% |
| Current investments | 50/53 | €75,000 | €112,373 | +€37,373 | +49.8% |
| Cash at bank and in hand | 54/58 | €20,220 | €62,615 | +€42,395 | +210% |
| Deferred charges and accrued income | 490/1 | €29,969 | €10,212 | -€19,757 | -65.9% |
| Total equity and liabilities | 10/49 | €156,728 | €227,234 | +€70,506 | +45.0% |
| Equity | 10/15 | €133,804 | €208,889 | +€75,085 | +56.1% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €130,804 | €205,889 | +€75,085 | +57.4% |
| Amounts payable | 17/49 | €22,924 | €18,345 | -€4,579 | -20.0% |
| Amounts payable within one year | 42/48 | €22,659 | €17,863 | -€4,796 | -21.2% |
| Financial debts | 43 | €1,682 | €162 | -€1,520 | -90.4% |
| Credit institutions | 430/8 | €1,682 | €162 | -€1,520 | -90.4% |
| Trade debts | 44 | €2,363 | €1,331 | -€1,032 | -43.7% |
| Suppliers | 440/4 | €2,363 | €1,331 | -€1,032 | -43.7% |
| Taxes, remuneration and social security | 45 | €17,951 | €15,570 | -€2,380 | -13.3% |
| Taxes | 450/3 | €16,426 | €13,565 | -€2,862 | -17.4% |
| Remuneration and social security | 454/9 | €1,524 | €2,005 | +€481 | +31.6% |
| Other amounts payable | 47/48 | €664 | €800 | +€136 | +20.5% |
| Accrued charges and deferred income | 492/3 | €265 | €482 | +€217 | +82.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €108 | €1,233 | +€1,124 | +1,041% |
| Other operating charges | 640/8 | €832 | €407 | -€424 | -51.0% |
| Gross operating margin | 9900 | €171,249 | €97,756 | -€73,492 | -42.9% |
| Operating profit (loss) | 9901 | €170,309 | €96,116 | -€74,193 | -43.6% |
| Financial income | 75/76B | €1,833 | €2,937 | +€1,104 | +60.3% |
| Recurring financial income | 75 | €1,833 | €2,937 | +€1,104 | +60.3% |
| Financial charges | 65/66B | €1,548 | €1,189 | -€360 | -23.2% |
| Recurring financial charges | 65 | €1,548 | €1,189 | -€360 | -23.2% |
| Profit (loss) for the period before taxes | 9903 | €170,593 | €97,865 | -€72,729 | -42.6% |
| Income taxes | 67/77 | €39,125 | €21,979 | -€17,146 | -43.8% |
| Profit (loss) for the period | 9904 | €131,468 | €75,885 | -€55,583 | -42.3% |
| Profit (loss) for the period to be appropriated | 9905 | €131,468 | €75,885 | -€55,583 | -42.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.